Safety
Cagrilintide
Adverse-event report summary for Cagrilintide, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 4
- Reports flagged serious
- 3
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Dyspnoea2 reports
- Anal Incontinence1 reports
- Body Mass Index Decreased1 reports
- Decreased Appetite1 reports
- Gastroenteritis1 reports
- Illness1 reports
- Loss Of Consciousness1 reports
- Nausea1 reports
- Product Information Content Complaint1 reports
- Pruritus1 reports
- Throat Tightness1 reports
- Thyroid Mass1 reports
- Urticaria1 reports
- Vomiting1 reports
- Weight Decreased1 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.